Years of life lost as a measure of cancer burden on a national level

por Brustugun, O T, Møller, B, Helland, Å
Publicado 2014

PReS-FINAL-2036: Proteins of the lectin pathway of the complement system in juvenile idiopathic arthritis

por Petri, C, Thiel, S, Jensenius, JC, Kuno-Møller, B, Herlin, T
Publicado 2013

Pooled retrospective analysis of 70 mg erenumab in episodic and chronic migraine: a two tertiary headache centers experience during clinical practice

por Storch, P., Burow, P., Möller, B., Kraya, T., Heintz, S., Politz, N., Naegel, S.
Publicado 2021

The future burden of cancer in England: incidence and numbers of new patients in 2020

por Møller, H, Fairley, L, Coupland, V, Okello, C, Green, M, Forman, D, Møller, B, Bray, F
Publicado 2007

Promoter polymorphisms in the IL-18 gene are associated with rheumatoid arthritis in two independent clinical cohorts

por Gracie, JA, Koyama, N, Field, M, McGarry, F, Schobel, A, McInnes, IB, Moller, B
Publicado 2003

Utilization of a high-throughput shoot imaging system to examine the dynamic phenotypic responses of a C(4) cereal crop plant to nitrogen and water deficiency over time

por Neilson, E. H., Edwards, A. M., Blomstedt, C. K., Berger, B., Møller, B. Lindberg, Gleadow, R. M.
Publicado 2015

Safety, tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety Trial

por Witthöft, Th, Möller, B, Wiedmann, K H, Mauss, St, Link, R, Lohmeyer, J, Lafrenz, M, Gelbmann, C M, Hüppe, D, Niederau, C, Alshuth, U
Publicado 2007

Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an a...

por Finckh, A, Ciurea, A, Brulhart, L, Möller, B, Walker, U A, Courvoisier, D, Kyburz, D, Dudler, J, Gabay, C, Arthritis, on the behalf of the doctors of the Swiss Clinical Quality Management Programme for Rheumatoid
Publicado 2010

Airborne concentrations and chemical considerations of radioactive ruthenium from an undeclared major nuclear release in 2017

por Masson, O., Steinhauser, G., Zok, D., Saunier, O., Angelov, H., Babić, D., Bečková, V., Bieringer, J., Bruggeman, M., Burbidge, C. I., Conil, S., Dalheimer, A., De Geer, L.-E., de Vismes Ott, A., Eleftheriadis, K., Estier, S., Fischer, H., Garavaglia, M. G., Gasco Leonarte, C., Gorzkiewicz, K., Hainz, D., Hoffman, I., Hýža, M., Isajenko, K., Karhunen, T., Kastlander, J., Katzlberger, C., Kierepko, R., Knetsch, G.-J., Kövendiné Kónyi, J., Lecomte, M., Mietelski, J. W., Min, P., Møller, B., Nielsen, S. P., Nikolic, J., Nikolovska, L., Penev, I., Petrinec, B., Povinec, P. P., Querfeld, R., Raimondi, O., Ransby, D., Ringer, W., Romanenko, O., Rusconi, R., Saey, P. R. J., Samsonov, V., Šilobritienė, B., Simion, E., Söderström, C., Šoštarić, M., Steinkopff, T., Steinmann, P., Sýkora, I., Tabachnyi, L., Todorovic, D., Tomankiewicz, E., Tschiersch, J., Tsibranski, R., Tzortzis, M., Ungar, K., Vidic, A., Weller, A., Wershofen, H., Zagyvai, P., Zalewska, T., Zapata García, D., Zorko, B.
Publicado 2019